Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1993 Feb;70(2):165-70.

Effect of inhaled beclomethasone dipropionate on bronchial responsiveness in patients with asthma

T Katsunuma  1 , K Hashimoto, K Akimoto, M Ebisawa, Y Iikura
Affiliations
  • PMID: 8430924
Clinical Trial

Effect of inhaled beclomethasone dipropionate on bronchial responsiveness in patients with asthma

T Katsunuma et al. Ann Allergy. 1993 Feb.

Abstract

We investigated the effect of 300 micrograms of inhaled beclomethasone dipropionate (BDP) daily on bronchial responsiveness to methacholine and pulmonary function of 22 subjects with asthma in a single-blind, crossover study. The severity of bronchial hyperresponsiveness lessened significantly during treatment with BDP (P < .01). No significant changes occurred in FEV1 or in the control value of airway conductance. We conclude that a 300-micrograms total daily dose of BDP is an efficacious treatment for patients with asthma. Because suppression of adrenal function and systemic adverse effects can occur in asthmatic patients treated with inhaled corticosteroids, especially children, long-term treatment with inhaled steroids should employ minimal daily doses necessary.

PubMed Disclaimer

Publication types